Tag Archives: ALU

Top 10 Blue Chip Stocks To Invest In 2019

Lee Danner & Bass Inc. lowered its stake in shares of iShares Russell 1000 ETF (NYSEARCA:IWB) by 8.2% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,370 shares of the company’s stock after selling 570 shares during the quarter. Lee Danner & Bass Inc.’s holdings in iShares Russell 1000 ETF were worth $997,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. HC Financial Advisors Inc. acquired a new position in iShares Russell 1000 ETF during the 4th quarter worth $494,000. RMB Capital Management LLC boosted its position in iShares Russell 1000 ETF by 21.9% during the 1st quarter. RMB Capital Management LLC now owns 10,980 shares of the company’s stock worth $1,613,000 after acquiring an additional 1,975 shares during the period. Jump Trading LLC acquired a new position in iShares Russell 1000 ETF during the 1st quarter worth $1,100,000. Davis R M Inc. acquired a new position in iShares Russell 1000 ETF during the 2nd quarter worth $260,000. Finally, Blue Chip Wealth Management Inc. acquired a new position in iShares Russell 1000 ETF during the 1st quarter worth $265,000.

Top 10 Blue Chip Stocks To Invest In 2019: Anavex Life Sciences Corp.(AVXL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Anavex Life Sciences (NASDAQ:AVXL)’s share price shot up 4.8% during mid-day trading on Tuesday . The company traded as high as $4.35 and last traded at $3.93. 14,995 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 606,708 shares. The stock had previously closed at $4.13.

  • [By Joseph Griffin]

    News stories about Anavex Life Sciences (NASDAQ:AVXL) have trended somewhat positive recently, Accern reports. The research group identifies negative and positive media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Anavex Life Sciences earned a media sentiment score of 0.08 on Accern’s scale. Accern also assigned news headlines about the biotechnology company an impact score of 46.1730416635586 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

  • [By Shane Hupp]

    Here are some of the media stories that may have effected Accern’s analysis:

    Get Anavex Life Sciences alerts:

    Comparing Anavex Life Sciences (AVXL) & Viralytics (VRACY) (americanbankingnews.com) Hot Move to Watch Anavex Life Sciences Corp. (AVXL) (nasdaqplace.com) Anavex Life Sciences (AVXL) and Intrexon (XON) Head to Head Review (americanbankingnews.com) -$0.10 EPS Expected for Anavex Life Sciences (AVXL) This Quarter (americanbankingnews.com)

    A number of equities analysts recently issued reports on the stock. Maxim Group reaffirmed a “buy” rating and set a $7.00 target price (up previously from $5.00) on shares of Anavex Life Sciences in a research report on Thursday, May 31st. Zacks Investment Research lowered shares of Anavex Life Sciences from a “buy” rating to a “hold” rating in a research report on Friday, March 23rd. Noble Financial set a $7.00 target price on shares of Anavex Life Sciences and gave the stock a “buy” rating in a research report on Wednesday, May 16th. HC Wainwright assumed coverage on shares of Anavex Life Sciences in a research report on Wednesday, May 30th. They set a “buy” rating and a $10.00 target price on the stock. Finally, Roth Capital initiated coverage on shares of Anavex Life Sciences in a research report on Thursday, March 8th. They set a “buy” rating and a $6.00 target price on the stock. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. Anavex Life Sciences presently has an average rating of “Buy” and an average target price of $6.55.

  • [By Joseph Griffin]

    News coverage about Anavex Life Sciences (NASDAQ:AVXL) has been trending somewhat positive on Wednesday, according to Accern. The research firm identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Anavex Life Sciences earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned headlines about the biotechnology company an impact score of 46.5362495493017 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Stephan Byrd]

    Schwab Charles Investment Management Inc. lifted its stake in Anavex Life Sciences Corp (NASDAQ:AVXL) by 48.8% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 76,200 shares of the biotechnology company’s stock after purchasing an additional 25,000 shares during the period. Schwab Charles Investment Management Inc.’s holdings in Anavex Life Sciences were worth $211,000 at the end of the most recent quarter.

Top 10 Blue Chip Stocks To Invest In 2019: Hostess Brands, Inc. (TWNK)

Advisors’ Opinion:

  • [By Logan Wallace]

    Vertical Research assumed coverage on shares of Hostess Brands (NASDAQ:TWNK) in a research report sent to investors on Monday morning. The brokerage issued a buy rating on the stock.

  • [By Trey Thoelcke]

    For a little more high-profile option, there is Hostess Brands Inc. (NASDAQ: TWNK), which has a market cap over $1 billion dollars. It is, of course, the maker of Twinkies and so much more.

  • [By Stephan Byrd]

    Shares of Hostess Brands Inc (NASDAQ:TWNK) have received a consensus recommendation of “Hold” from the thirteen research firms that are presently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $15.00.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Hostess Brands (TWNK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Hostess Brands (TWNK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Blue Chip Stocks To Invest In 2019: Evolving Systems, Inc.(EVOL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Evolving Systems (NASDAQ: EVOL) and Zscaler (NASDAQ:ZS) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation.

Top 10 Blue Chip Stocks To Invest In 2019: Estee Lauder Companies, Inc. (EL)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Estee Lauder Companies Inc. (NYSE: EL) was started as Outperform with a $170 price target (versus a $147.88 close) at Evercore ISI.

    Intuit Inc. (NASDAQ: INTU) was downgraded to Underweight from Equal Weight with a $160 price target (versus a $190.54 close) at First Analysis. Credit Suisse maintained its Outperform rating but raised its target price to $215 from $195.

  • [By Ethan Ryder]

    Estée Lauder Companies (NYSE:EL)‘s stock had its “buy” rating reiterated by Wells Fargo in a note issued to investors on Monday. They currently have a $168.00 price objective on the stock. Wells Fargo’s target price points to a potential upside of 13.61% from the company’s previous close.

  • [By Joseph Griffin]

    Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its position in Estee Lauder Companies Inc (NYSE:EL) by 10.2% in the 4th quarter, Holdings Channel reports. The firm owned 214,126 shares of the company’s stock after acquiring an additional 19,879 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in Estee Lauder Companies were worth $26,911,000 as of its most recent filing with the SEC.

  • [By Ethan Ryder]

    Estee Lauder Companies Inc (NYSE:EL) shares gapped down before the market opened on Monday . The stock had previously closed at $156.97, but opened at $152.93. Estee Lauder Companies shares last traded at $145.62, with a volume of 2849125 shares trading hands.

  • [By Shane Hupp]

    Estee Lauder Companies Inc (NYSE:EL) announced a quarterly dividend on Monday, August 20th, RTT News reports. Shareholders of record on Friday, August 31st will be given a dividend of 0.38 per share on Monday, September 17th. This represents a $1.52 dividend on an annualized basis and a yield of 1.12%. The ex-dividend date is Thursday, August 30th.

  • [By Motley Fool Staff]

    The cast reaches for the mailbag in this segment from Industry Focus: Consumer Goods. Listener Joseph wants to know why Estée Lauder (NYSE:EL) and Ulta Beauty (NASDAQ:ULTA), both leading names in the skincare and cosmetics industry, have seen their stocks move in opposite directions over the past year.

Top 10 Blue Chip Stocks To Invest In 2019: Alcatel Lucent(ALU)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Media coverage about Alcatel Lucent (NYSE:ALU) has been trending somewhat positive this week, Accern reports. The research group identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Alcatel Lucent earned a media sentiment score of 0.08 on Accern’s scale. Accern also gave headlines about the communications equipment provider an impact score of 45.9413628150958 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Joseph Griffin]

    In related news, insider Sergiy Kostynsky 250,000 shares of the business’s stock in a transaction dated Monday, November 26th. Also, insider Lynn Mickleburgh acquired 6,800 shares of Altium stock in a transaction that occurred on Friday, December 28th. The shares were bought at an average price of A$14.74 ($10.45) per share, for a total transaction of A$100,232.00 ($71,086.52).

    ILLEGAL ACTIVITY NOTICE: “Altium Limited Announces Interim Dividend of $0.16 (ALU)” was reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece on another domain, it was copied illegally and republished in violation of United States & international copyright & trademark law. The correct version of this piece can be accessed at www.tickerreport.com/banking-finance/4164167/altium-limited-announces-interim-dividend-of-0-16-alu.html.

    About Altium

  • [By Joseph Griffin]

    Press coverage about Alcatel Lucent (NYSE:ALU) has been trending positive on Monday, according to Accern Sentiment. The research group ranks the sentiment of news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Alcatel Lucent earned a news sentiment score of 0.27 on Accern’s scale. Accern also assigned headlines about the communications equipment provider an impact score of 48.5554072096128 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Top 10 Blue Chip Stocks To Invest In 2019: China Automotive Systems, Inc.(CAAS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    News stories about China Automotive Systems (NASDAQ:CAAS) have been trending somewhat positive on Wednesday, according to Accern Sentiment. Accern identifies negative and positive news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. China Automotive Systems earned a news impact score of 0.00 on Accern’s scale. Accern also gave media headlines about the auto parts company an impact score of 47.4904091752746 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

  • [By Logan Wallace]

    Media coverage about China Automotive Systems (NASDAQ:CAAS) has been trending somewhat positive on Saturday, according to Accern Sentiment. The research group ranks the sentiment of media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. China Automotive Systems earned a coverage optimism score of 0.04 on Accern’s scale. Accern also gave media stories about the auto parts company an impact score of 45.9702420023483 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

  • [By Max Byerly]

    Icahn Enterprises LP Common Stock (NASDAQ: CAAS) and China Automotive Systems (NASDAQ:CAAS) are both multi-sector conglomerates companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation.

  • [By Joseph Griffin]

    Tenneco (NYSE: TEN) and China Automotive Systems (NASDAQ:CAAS) are both auto/tires/trucks companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, dividends and valuation.

  • [By Joseph Griffin]

    TRADEMARK VIOLATION WARNING: “Brokerages Expect China Automotive Systems (CAAS) to Post $0.18 Earnings Per Share” was originally reported by Ticker Report and is the property of of Ticker Report. If you are reading this news story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this news story can be read at www.tickerreport.com/banking-finance/3349149/brokerages-expect-china-automotive-systems-caas-to-post-0-18-earnings-per-share.html.

Top 10 Blue Chip Stocks To Invest In 2019: Virtusa Corporation(VRTU)

Advisors’ Opinion:

  • [By Max Byerly]

    Virtusa (NASDAQ:VRTU) – Equities research analysts at SunTrust Banks issued their Q1 2020 earnings per share (EPS) estimates for shares of Virtusa in a report released on Wednesday, May 16th. SunTrust Banks analyst F. Atkins expects that the information technology services provider will post earnings of $0.33 per share for the quarter. SunTrust Banks currently has a “Hold” rating on the stock. SunTrust Banks also issued estimates for Virtusa’s Q2 2020 earnings at $0.46 EPS, Q3 2020 earnings at $0.56 EPS and Q4 2020 earnings at $0.60 EPS.

  • [By Max Byerly]

    Sei Investments Co. reduced its stake in Virtusa Co. (NASDAQ:VRTU) by 5.5% during the 1st quarter, HoldingsChannel reports. The fund owned 21,835 shares of the information technology services provider’s stock after selling 1,275 shares during the period. Sei Investments Co.’s holdings in Virtusa were worth $1,058,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Virtusa (NASDAQ:VRTU) had its target price lifted by equities research analysts at Wedbush from $60.00 to $70.00 in a research report issued to clients and investors on Friday. The brokerage currently has an “outperform” rating on the information technology services provider’s stock. Wedbush’s price target suggests a potential upside of 23.09% from the company’s current price.

  • [By Lisa Levin]

    Virtusa Corporation (NASDAQ: VRTU) is projected to report quarterly earnings at $0.55 per share on revenue of $279.85 million.

    Kamada Ltd. (NASDAQ: KMDA) is expected to report quarterly earnings at $0.02 per share on revenue of $24.02 million.

  • [By Ethan Ryder]

    Voya Investment Management LLC boosted its stake in Virtusa Co. (NASDAQ:VRTU) by 105.7% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 280,742 shares of the information technology services provider’s stock after acquiring an additional 144,258 shares during the period. Voya Investment Management LLC’s holdings in Virtusa were worth $13,666,000 as of its most recent SEC filing.

Top 10 Blue Chip Stocks To Invest In 2019: Foundation Medicine, Inc.(FMI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of Foundation Medicine Inc (NASDAQ:FMI) hit a new 52-week high and low on Tuesday . The company traded as low as $108.65 and last traded at $107.25, with a volume of 22037 shares trading hands. The stock had previously closed at $107.20.

  • [By Motley Fool Staff]

    Only months after a standstill agreement between the two companies expired, biopharma giant Roche Holdings (NASDAQOTH:RHHBY) has agreed to acquire Foundation Medicine (NASDAQ:FMI) lock, stock, and barrel. Roche had already owned more than half of Foundation Medicine, so the decision to buy the company outright shows it’s more confident in the future of personalized cancer treatment than ever before. Is this deal a needle-mover?

  • [By Todd Campbell]

    Technology stocks are staples in growth portfolios because of their eye-popping revenue growth, but technology isn’t the only sector of the stock market that boasts fast-growing companies. For example, many healthcare stocks are growing at rates that Silicon Valley would envy. In fact, Foundation Medicine (NASDAQ:FMI), Exelixis Corp (NASDAQ:EXEL), and Teladoc (NYSE:TDOC) all reported year-over-year sales growth north of 100% in first-quarter 2018.

  • [By Dan Caplinger]

    Wall Street continued to struggle on Tuesday, with major benchmarks posting larger losses than those seen in recent sessions. A new round of escalation in trade conflict between the U.S. and China was the proximate cause for concerns among investors, as the White House threatened to add tariffs on another $200 billion in Chinese goods. Despite the broader worries, some companies still had good news that sent their individual shares higher. CVS Health (NYSE:CVS), Foundation Medicine (NASDAQ:FMI), and Solid Biosciences (NASDAQ:SLDB) were among the best performers on the day. Here’s why they did so well.

  • [By Chris Lange]

    Foundation Medicine Inc. (NASDAQ: FMI) shares saw a sizable jump early on Tuesday after the company announced that Roche would be acquiring all the outstanding shares. The closing of the transaction is expected to take place in the second half of 2018.

  • [By Todd Campbell]

    After announcing that Roche Holdings (NASDAQOTH:RHHBY) will acquire it for $137 per share in cash, shares in Foundation Medicine (NASDAQ:FMI) are soaring 28.3% at 11:30 a.m. EDT today.

Top 10 Blue Chip Stocks To Invest In 2019: Armstrong World Industries Inc(AWI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Alps Advisors Inc. bought a new position in Armstrong World Industries Inc (NYSE:AWI) during the second quarter, Holdings Channel reports. The fund bought 9,639 shares of the construction company’s stock, valued at approximately $584,000.

  • [By Stephan Byrd]

    Armstrong World Industries Inc (NYSE:AWI) insider Valueact Capital Master Fund, sold 30,000 shares of Armstrong World Industries stock in a transaction that occurred on Tuesday, August 21st. The shares were sold at an average price of $70.11, for a total transaction of $2,103,300.00. The transaction was disclosed in a filing with the SEC, which is available at this link.

  • [By Ethan Ryder]

    AptarGroup (NYSE: ATR) and Armstrong World Industries (NYSE:AWI) are both mid-cap industrial products companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, institutional ownership and profitability.

  • [By Lee Samaha]

    The move can be put down to an improvement in sentiment toward the homebuilding products sector. After all, Beacon Roofing Supply (NASDAQ:BECN) gained 15%, while other housing stocks in the sector, such as ceilings company Armstrong World Industries (NYSE:AWI) and plumbing products company Masco (NYSE:MAS), also went up by double digits in the month.

Top 10 Blue Chip Stocks To Invest In 2019: Harsco Corporation(HSC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    HashCoin (CURRENCY:HSC) traded up 2.5% against the dollar during the 1-day period ending at 17:00 PM ET on July 17th. One HashCoin token can now be purchased for about $0.0025 or 0.00000034 BTC on exchanges including Gate.io and BCEX. HashCoin has a market cap of $0.00 and $2.52 million worth of HashCoin was traded on exchanges in the last day. During the last week, HashCoin has traded 3.7% higher against the dollar.

  • [By Joseph Griffin]

    HashCoin (CURRENCY:HSC) traded 2.5% lower against the US dollar during the 1 day period ending at 20:00 PM ET on September 30th. HashCoin has a total market capitalization of $0.00 and $28,133.00 worth of HashCoin was traded on exchanges in the last day. One HashCoin token can currently be purchased for approximately $0.0004 or 0.00000005 BTC on exchanges including Gate.io and BCEX. Over the last week, HashCoin has traded down 5.5% against the US dollar.

  • [By Ethan Ryder]

    HashCoin (CURRENCY:HSC) traded up 2.7% against the US dollar during the 24-hour period ending at 20:00 PM ET on March 6th. HashCoin has a total market cap of $1.21 million and approximately $1,110.00 worth of HashCoin was traded on exchanges in the last 24 hours. One HashCoin token can currently be purchased for $0.0001 or 0.00000002 BTC on exchanges including BCEX and Gate.io. In the last week, HashCoin has traded 0.4% lower against the US dollar.

  • [By Stephan Byrd]

    Harsco Co. (NYSE:HSC) has earned an average recommendation of “Buy” from the eight ratings firms that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $29.50.

  • [By Ethan Ryder]

    Harsco (NYSE:HSC) – Research analysts at KeyCorp lifted their Q2 2018 earnings estimates for Harsco in a report issued on Wednesday, May 2nd. KeyCorp analyst J. Hammond now expects that the industrial products company will post earnings per share of $0.35 for the quarter, up from their prior forecast of $0.31. KeyCorp has a “Overweight” rating and a $27.00 price objective on the stock. KeyCorp also issued estimates for Harsco’s Q3 2018 earnings at $0.36 EPS, Q4 2018 earnings at $0.27 EPS, FY2018 earnings at $1.20 EPS and FY2019 earnings at $1.35 EPS.